These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 27084911

  • 1. Predictors of Organ Damage Progression and Effect on Health-related Quality of Life in Systemic Lupus Erythematosus.
    Legge A, Doucette S, Hanly JG.
    J Rheumatol; 2016 Jun; 43(6):1050-6. PubMed ID: 27084911
    [Abstract] [Full Text] [Related]

  • 2. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC, Ho LY, Cheung MY, Yu KL, To CH.
    Scand J Rheumatol; 2009 Jun; 38(2):121-7. PubMed ID: 18991189
    [Abstract] [Full Text] [Related]

  • 3. Charlson Comorbidity Index Is Related to Organ Damage in Systemic Lupus Erythematosus: Data from KORean lupus Network (KORNET) Registry.
    Kim SK, Choe JY, Lee SS.
    J Rheumatol; 2017 Apr; 44(4):452-458. PubMed ID: 28298561
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index.
    Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin PR, Gladman DD, Urowitz MB, Bruce IN, Isenberg DA, Rahman A, Alarcón GS, Petri M, Khamashta MA, Dooley MA, Ramsey-Goldman R, Manzi S, Zoma AA, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, van Vollenhoven RF, Jonsen A, Nived O, Ramos-Casals M, Kamen DL, Kalunian KC, Jacobsen S, Peschken CA, Askanase A, Hanly JG.
    Arthritis Rheumatol; 2020 Apr; 72(4):658-666. PubMed ID: 31631584
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations.
    Joo YB, Bae SC.
    Int J Rheum Dis; 2015 Feb; 18(2):117-28. PubMed ID: 25524656
    [Abstract] [Full Text] [Related]

  • 8. Association of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index with measures of disease activity and health status in patients with systemic lupus erythematosus.
    Stoll T, Stucki G, Malik J, Pyke S, Isenberg DA.
    J Rheumatol; 1997 Feb; 24(2):309-13. PubMed ID: 9034988
    [Abstract] [Full Text] [Related]

  • 9. Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort.
    Petri M, Purvey S, Fang H, Magder LS.
    Arthritis Rheum; 2012 Dec; 64(12):4021-8. PubMed ID: 22932985
    [Abstract] [Full Text] [Related]

  • 10. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H, Wetterö J, Skogh T, Sjöwall C.
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [Abstract] [Full Text] [Related]

  • 11. Factors associated with health-related quality of life in Peruvian patients with systemic lupus erythematosus.
    Elera-Fitzcarrald C, Alva M, Gamboa-Cardenas R, Mora-Trujillo CS, Zevallos F, García-Poma A, Medina M, Rodriguez-Bellido Z, Perich-Campos RA, Pastor-Asurza CA, Segami MI, Ugarte-Gil MF.
    Lupus; 2018 May; 27(6):913-919. PubMed ID: 29301472
    [Abstract] [Full Text] [Related]

  • 12. Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus.
    Enocsson H, Wirestam L, Dahle C, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma AA, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, van Vollenhoven RF, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken CA, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C.
    J Autoimmun; 2020 Jan; 106():102340. PubMed ID: 31629628
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Predictors of damage progression in Portuguese patients with systemic lupus erythematosus.
    Santos MJ, Vinagre F, Nero P, Barcelos F, Barcelos A, Rodrigues AM, de Matos AA, Silva C, Miranda L, Capela S, Marques A, Branco J, da Silva JC.
    Ann N Y Acad Sci; 2009 Sep; 1173():822-8. PubMed ID: 19758234
    [Abstract] [Full Text] [Related]

  • 15. Smoking and Its Association With Morbidity in Systemic Lupus Erythematosus Evaluated by the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index: Preliminary Data and Systematic Review.
    Montes RA, Mocarzel LO, Lanzieri PG, Lopes LM, Carvalho A, Almeida JR.
    Arthritis Rheumatol; 2016 Feb; 68(2):441-8. PubMed ID: 26359794
    [Abstract] [Full Text] [Related]

  • 16. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F, Ceccarelli F, Perricone C, Leccese I, Massaro L, Pacucci VA, Truglia S, Miranda F, Spinelli FR, Alessandri C, Valesini G.
    Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.
    Wang M, Gladman DD, Ibañez D, Urowitz MB.
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):833-7. PubMed ID: 22290935
    [Abstract] [Full Text] [Related]

  • 19. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual.
    Alarcón GS, McGwin G, Bartolucci AA, Roseman J, Lisse J, Fessler BJ, Bastian HM, Friedman AW, Reveille JD, LUMINA Study Group. Lupus in Minority Populations, Nature versus Nurture.
    Arthritis Rheum; 2001 Dec; 44(12):2797-806. PubMed ID: 11762940
    [Abstract] [Full Text] [Related]

  • 20. Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort.
    Watson L, Leone V, Pilkington C, Tullus K, Rangaraj S, McDonagh JE, Gardner-Medwin J, Wilkinson N, Riley P, Tizard J, Armon K, Sinha MD, Ioannou Y, Archer N, Bailey K, Davidson J, Baildam EM, Cleary G, McCann LJ, Beresford MW, UK Juvenile-Onset Systemic Lupus Erythematosus Study Group.
    Arthritis Rheum; 2012 Jul; 64(7):2356-65. PubMed ID: 22294381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.